2 high-growth stocks you might regret not buying

Roland Head highlights two exciting growth stocks with the potential to be millionaire-makers.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Shares of small-cap fund manager Miton Group (LSE: MGR) clocked up a 9% gain on Friday morning after the company said that results for 2017 should “exceed market expectations”.

This is the second time this year that Miton has forced City analysts to upgrade their estimates. The business is often overlooked by private investors due to its modest £65m market cap, but in my view it’s potentially a better buy than some larger rivals.

Still looks cheap to me

At the end of October, the group had £3,635m of assets under management. It said that it has seen net inflows of new investor cash over the second half of the year and this suggests rising demand for the group’s investment expertise, much of which is focused on small-cap stocks.

Another attraction is that the group’s top fund manager, Gervais Williams, has a 6.88% stake in the firm. Mr Williams also has a seat on the board, so I think it’s fair to say that the company is unlikely to take short-term risks that could sacrifice long-term growth. Although he could unsettle the market if he ever chose to leave, this seems unlikely at present. On balance, I believe management interests are well aligned with those of shareholders.

Miton shares have risen by 28% over the last year, and by 69% over the last five years. Despite these gains, the stock currently trades on a forecast P/E of around 14, falling to a P/E of about 12 for 2018.

The dividend payout has grown at an average of 20% per year since 2011. A payout of 1.1p per share is expected this year, giving a forecast yield of around 3.1%. I believe further growth is likely in 2018, given the group’s debt-free balance sheet and strong cash generation.

In my view, Miton certainly rates as a potential buy after today’s news.

Follow the expert money

Miton’s strength is its expert team of specialist fund managers. For investors with an interest in small-cap mining stocks, that kind of expertise is often hard to find. Companies can appear credible but later prove disappointing.

One way to select potential winners is to follow the investments of larger mining firms. For example, the Cascabel project owned by gold and copper miner SolGold (LSE: SOLG) looked an uncertain bet for many years, until autumn 2016, when the group secured financial backing from A$18bn firm Newcrest Mining Limited.

Newcrest has since invested $63m in SolGold in exchange for a 14.54% holding in the company. Based on information in the latest presentation, I estimate that the average share price paid by Newcrest so far is about 30p.

However, SolGold shares currently trade at about 27p, giving us the opportunity to invest at roughly the same price Newcrest has been happy to pay.

SolGold believes that Cascabel could be a world-class discovery, with as much as 10bn tonnes of ore potentially containing 60m tonnes each of gold and copper. The company is now well funded for now, with a supportive industry investor.

Although this is only a small investment for Newcrest, which reported a profit of A$408m last year, I believe SolGold shares could be a good long-term buy at current levels as part of a diversified portfolio.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Roland Head has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

After it crashed 25%, should I buy this former stock market darling in my Stocks and Shares ISA?

Harvey Jones has a big hole in his Stocks and Shares ISA that he is keen to fill. Should he…

Read more »

happy senior couple using a laptop in their living room to look at their financial budgets
Investing Articles

How’s the dividend forecast looking for Legal & General shares in 2025 and beyond?

As a shareholder, I like to keep track of the potential dividend returns I could make from my Legal &…

Read more »

artificial intelligence investing algorithms
Investing Articles

Could buying this stock with a $7bn market cap be like investing in Nvidia in 2010?

Where might the next Nvidia-type stock be lurking in today's market? Our writer takes a look at one candidate with…

Read more »

Investing Articles

Is GSK a bargain now the share price is near 1,333p?

Biopharma company GSK looks like a decent stock to consider for the long term, so is today's lower share price…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

Could December be a great month to buy UK shares?

Christopher Ruane sees some possible reasons to look for shares to buy in December -- but he'll be using the…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

Sticking to FTSE shares, I’d still aim for a £1,000 monthly passive income like this!

By investing in blue-chip FTSE shares with proven business models, our writer hopes he can build sizeable passive income streams…

Read more »

Growth Shares

BT shares? I think there are much better UK stocks for the long term

Over the long term, many UK stocks have performed much better than BT. Here’s a look at two companies that…

Read more »

British Pennies on a Pound Note
Investing Articles

After a 540% rise, could this penny share keep going?

This penny share has seen mixed fortunes in recent years. Our writer looks ahead to some potentially exciting developments in…

Read more »